Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Comparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients

    Recruiting

    1 1 1 1
    France
  • Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Bulgaria Croatia France Germany Hungary +5
  • Study on the Safety of Bomedemstat for Patients with Myeloproliferative Neoplasms Who Participated in a Previous Bomedemstat Study

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Not yet recruiting

    1 1 1 1
    France
  • Study on the Safety and Effectiveness of Peginterferon Alfa-2a and Ruxolitinib for Newly Diagnosed Polycythemia Vera Patients

    Not yet recruiting

    1 1 1
    Denmark
  • Study of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    1 1 1 1
    Germany Italy Poland Sweden
  • Study on the Effects of Rusfertide (PTG-300) for Patients with Polycythemia Vera

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Hungary +5
  • Study on the Effects of Sapablursen for Patients with Phlebotomy Dependent Polycythemia Vera

    Not recruiting

    1 1
    Investigated drugs:
    Poland
  • Study on Hydroxycarbamide Resistance in Patients with Polycythemia Vera Identified by AI Predictors

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany